Results: (1) 92.2% patients have bleeding symptom, from which 60.8% have bleeding in more than 2 sites; (2) 84.3% patients have reduced platelet coung < 50 G / l, 88.2% have at least 2 tests result abnormalities and 74.5% have DIC.